BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25676272)

  • 1. Changes in thyroglobulin antibodies after treatment of differentiated thyroid cancer and its influencing factors.
    Cong H; Liang J; Li F; Qiu WS; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Feb; 37(1):61-5. PubMed ID: 25676272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Selenious Yeast Tablets on the Thyroglobulin Antibody Level in ThyroglobulinAntibody-positive Patients with Differentiated Thyroid Cancer].
    Cong H; Li H; Liang J; Yang K; Zhao T; Qiu WS; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Oct; 37(5):591-5. PubMed ID: 26564513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
    Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
    Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.
    Zhang T; Song LP; Zhao T; Gao W; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):539-543. PubMed ID: 28877833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroglobulin antibodies: Trend over time and clinical impact in differentiated thyroid carcinoma with and without radioiodine ablation.
    Iglesias ML; Calabretta JM; Coggiola O; Califano I
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Nov; 69(9):702-708. PubMed ID: 36470645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
    Görges R; Maniecki M; Jentzen W; Sheu SN; Mann K; Bockisch A; Janssen OE
    Eur J Endocrinol; 2005 Jul; 153(1):49-55. PubMed ID: 15994745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to disappearance of thyroglobulin antibodies and influencing factors in patients with papillary thyroid carcinoma.
    Li TJ; Lin YS; Liang J; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):258-61. PubMed ID: 22776660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome.
    Trimboli P; Zilioli V; Imperiali M; Giovanella L
    Clin Chem Lab Med; 2017 Oct; 55(12):1995-2001. PubMed ID: 28467308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer.
    Herman AE; Argersinger DP; Maksutova M; Morgan T; Hughes DT
    Endocr Pract; 2024 Feb; 30(2):89-94. PubMed ID: 37926368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
    Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
    Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.
    Morbelli S; Ferrarazzo G; Pomposelli E; Pupo F; Pesce G; Calamia I; Fiz F; Clapasson A; Bauckneht M; Minuto M; Sambuceti G; Giusti M; Bagnasco M
    J Endocrinol Invest; 2017 Apr; 40(4):417-424. PubMed ID: 27844413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
    Spencer C; Fatemi S
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
    Jo K; Kim MH; Ha J; Lim Y; Lee S; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):292-299. PubMed ID: 28493284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial Thyroglobulin Variation Trend Shortly after Radioiodine Therapy in Poorly to Moderately Differentiated Recurrent Thyroid Cancer.
    Li CX; Hou M; Ren C; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):351-5. PubMed ID: 27469925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.